KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Treasury Shares (2021 - 2024)

Bionano Genomics (BNGO) has disclosed Treasury Shares for 4 consecutive years, with $480.0 as the latest value for Q4 2024.

  • Quarterly Treasury Shares fell 88.0% to $480.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $480.0 through Dec 2024, down 88.0% year-over-year, with the annual reading at $480.0 for FY2024, 88.0% down from the prior year.
  • Treasury Shares hit $480.0 in Q4 2024 for Bionano Genomics, down from $29000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.5 million in Q1 2023 to a low of $480.0 in Q4 2024.
  • Historically, Treasury Shares has averaged $355113.8 across 4 years, with a median of $266000.0 in 2023.
  • Biggest YoY gain for Treasury Shares was 1834.48% in 2024; the steepest drop was 98.82% in 2024.
  • Year by year, Treasury Shares stood at $361000.0 in 2021, then tumbled by 97.23% to $10000.0 in 2022, then tumbled by 60.0% to $4000.0 in 2023, then plummeted by 88.0% to $480.0 in 2024.
  • Business Quant data shows Treasury Shares for BNGO at $480.0 in Q4 2024, $29000.0 in Q3 2024, and $561000.0 in Q2 2024.